Results 131 to 140 of about 161,793 (289)

Thymoglobulin after Matched Unrelated Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS Results in Improved Outcomes Comparable to Matched Related HCT

, 2016
Yasser Khaled, Rushang D. Patel, Wesam Ahmed, Shahram Mori, Melhem Solh   +4 more
openalex   +1 more source

The Impact of the 2016 EU Audit Reforms, Oversight, and Corruption on Earnings Management: Evidence From European Banks Using a Dynamic Panel Approach

International Journal of Finance &Economics, EarlyView.
ABSTRACT This study investigates earnings management in European banks in the context of the 2016 EU audit directive. Using a dynamic panel of 134 banks over 2012–2023, we apply two‐step System‐GMM estimators with three profitability measures—Earnings Before Provisions and Taxes (EBPT), Return on Assets (ROA), and Return on Equity (ROE).
Maria Christofidou, Epameinondas Katsikas, Dimitrios Koufopoulos, Konstantinos Spanos   +3 more
wiley   +1 more source

PS1020 SNP ARRAY REVEALS A NEW DELETION OF JAK2 IN AML PATIENTS

, 2019
Claudio Cerchione, Viviana Guadagnuolo, Cristina Papayannidis, Maria Chiara Fontana, Antonella Padella, Ilaria Iacobucci, Giorgia Simonetti, Giovanni Marconi, Stefania Paolini, Mariachiara Abbenante, Sarah Parisi, Francesca Volpato, Emanuela Ottaviani, Massimo Delledonne, Guido Biasco, Giovanni Martinelli   +15 more
openalex   +1 more source

Kryptonite for Cryptocurrencies? What Are the Effects of Regulatory Controls on Bitcoin Returns and Volatility?

International Journal of Finance &Economics, EarlyView.
ABSTRACT This paper examines the impact of regulatory controls on Bitcoin's excess returns and volatility. The paper innovates by proxying changes in the regulatory environment using global Google search volume intensity data. The generated regulatory indices accurately identify episodes of regulatory tightening within cryptocurrency markets.
Robert Mullings
wiley   +1 more source

New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML) [PDF]

, 2020
Jing Chen, Chana L. Glasser
openalex   +1 more source

Supplementary Table from Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts [PDF]

, 2023
Jana M. Ellegast, Gabriela Alexe, Amanda Hamze, Shan Lin, Hannah J. Uckelmann, Philipp J. Rauch, Maxim Pimkin, Linda S. Ross, Neekesh V. Dharia, Amanda L. Robichaud, Amy Saur Conway, Delan Khalid, Jennifer A. Perry, Mark Wunderlich, Lina Benajiba, Yana Pikman, Behnam Nabet, Nathanael S. Gray, Stuart H. Orkin, Kimberly Stegmaier   +19 more
openalex   +1 more source

Pediatric AML

, 2022
Pediatric AML is a heterogeneous disease and in 30% of cases no apparent driving aberration can be detected. In this thesis, we have investigated novel driving aberrations in pediatric AML to improve risk group stratification and potentially identify novel targets for therapy to ultimately improve outcome.
openaire   +1 more source

Artificial intelligence strategies for predicting kinase inhibitor resistance: A comprehensive review of methods, challenges, and future perspectives

Journal of Intelligent Medicine, EarlyView.
Abstract Kinase inhibitors are essential in targeted cancer therapy, yet resistance often emerges through secondary mutations, activation of compensatory signaling pathways, or drug‐efflux mechanisms. Artificial intelligence (AI) provides a workflow‐based strategy rather than a list of unrelated tools for predicting and addressing kinase‐inhibitor ...
Faris Hassan, Mohanad Ali Deifallah, Alaa Zaghloul, Rania Elgohary   +3 more
wiley   +1 more source

Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino, Cataldo Patruno, Francesca di Vico, Maddalena Napolitano   +3 more
wiley   +1 more source

Lycorine inhibits the proliferation of acute myeloid leukemia cells by upregulating the expression of THBS1. [PDF]

Ann Hematol
Wu L, Liu P, Jiang B, Zhang X, Zhao E, Zhao J, Zhu F, Xu H, Shi K, Jian B.   +9 more
europepmc   +1 more source